Literature DB >> 17115170

Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003.

Gudrun Høiseth1, Jørgen G Bramness, Asbjørg S Christophersen, Jørg Mørland.   

Abstract

Carisoprodol is commonly prescribed as a centrally acting muscle relaxant, but it is also subject to abuse. The literature describing fatal intoxications with the drug is limited to a relatively small number of cases, and there are inconsistencies with regard to which concentration levels that are toxic. We therefore investigated all forensic autopsies at the Norwegian Institute of Public Health during the period 1992-2003 where carisoprodol was detected. The median concentrations of carisoprodol in intoxication with carisoprodol only or with only minor other analytical findings was 36 mg/l (range 8-65 mg/l; n=5). In the rest of the intoxications, the relevance of carisoprodol relative to the other drugs detected was variable (n=93). When the number of intoxications with carisoprodol each year were divided by the number of defined daily doses (DDD) sold, a fatal toxicity index between 5.6 and 6.9 deaths/1 million DDD was obtained. The total number of cases where carisoprodol was detected increased during the period studied, which correlated to sales figures for the drug. We conclude that carisoprodol can be fatal in concentrations below those indicated in some of the previously published literature. There were, however, only a small number of cases where the cause of death can be attributed to use of carisoprodol alone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115170     DOI: 10.1007/s00414-006-0139-1

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  34 in total

1.  Drug and chemical blood-level data 2001.

Authors:  C L Winek; W W Wahba; C L Winek; T W Balzer
Journal:  Forensic Sci Int       Date:  2001-11-01       Impact factor: 2.395

2.  [Driving under the influence of medication and various substances other than alcohol].

Authors:  J Mørland
Journal:  Tidsskr Nor Laegeforen       Date:  2000-08-10

3.  [Centrally acting muscle relaxants and traffic hazards].

Authors:  J G Bramness; S Skurtveit; M Grung; J Mørland
Journal:  Tidsskr Nor Laegeforen       Date:  2000-06-30

Review 4.  Recent trends of drug abuse and drug-associated deaths in Korea.

Authors:  Heesun Chung; Meejung Park; Eunyoung Hahn; Haeyoung Choi; Hwakyung Choi; Miae Lim
Journal:  Ann N Y Acad Sci       Date:  2004-10       Impact factor: 5.691

Review 5.  Therapeutic and toxic blood concentrations of more than 500 drugs.

Authors:  M Schulz; A Schmoldt
Journal:  Pharmazie       Date:  1997-12       Impact factor: 1.267

6.  Carisoprodol: an unrecognized drug of abuse.

Authors:  David N Bailey; John R Briggs
Journal:  Am J Clin Pathol       Date:  2002-03       Impact factor: 2.493

7.  Carisoprodol (soma): abuse potential and physician unawareness.

Authors:  R R Reeves; O S Carter; H B Pinkofsky; F A Struve; D M Bennett
Journal:  J Addict Dis       Date:  1999

8.  Carisoprodol intoxications and serotonergic features.

Authors:  Jørgen G Bramness; Jørg Mørland; Hanne Kristin Sørlid; Nina Rudberg; Dag Jacobsen
Journal:  Clin Toxicol (Phila)       Date:  2005       Impact factor: 4.467

9.  Postmortem drug redistribution--human cases related to results in experimental animals.

Authors:  T Hilberg; S Rogde; J Mørland
Journal:  J Forensic Sci       Date:  1999-01       Impact factor: 1.832

10.  Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability.

Authors:  J D Roache; R R Griffiths
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

View more
  10 in total

1.  In vitro formation of ethanol in autopsy samples containing fluoride ions.

Authors:  Gudrun Høiseth; Lena Kristoffersen; Bente Larssen; Marianne Arnestad; Nils Olav Hermansen; Jørg Mørland
Journal:  Int J Legal Med       Date:  2007-03-27       Impact factor: 2.686

2.  Prevalence of adverse drug combinations in a large post-mortem toxicology database.

Authors:  Terhi Launiainen; Erkki Vuori; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2008-06-27       Impact factor: 2.686

3.  Interpretation of drug concentrations in an alternative matrix: the case of meprobamate in bile.

Authors:  L Fanton; F Bevalot; M P Gustin; C Z Paultre; C Le Meur; D Malicier
Journal:  Int J Legal Med       Date:  2008-06-26       Impact factor: 2.686

4.  Overdose of meprobamate: plasma concentration and Glasgow Coma Scale.

Authors:  Anne-Claire Buire; Fabien Vitry; Guillaume Hoizey; Denis Lamiable; Thierry Trenque
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

5.  An epidemic of fatal 3-methylfentanyl poisoning in Estonia.

Authors:  Ilkka Ojanperä; Merja Gergov; Milana Liiv; Aime Riikoja; Erkki Vuori
Journal:  Int J Legal Med       Date:  2008-04-03       Impact factor: 2.686

6.  Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database.

Authors:  Ilkka Ojanperä; Pirkko Kriikku; Erkki Vuori
Journal:  Int J Legal Med       Date:  2016-03-17       Impact factor: 2.686

7.  CYP2C19 genetics in fatal carisoprodol intoxications.

Authors:  Gudrun Høiseth; Umair Majid; Jørg Mørland; Jørgen G Bramness; Espen Molden
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

8.  Practical use of ethyl glucuronide and ethyl sulfate in postmortem cases as markers of antemortem alcohol ingestion.

Authors:  Gudrun Høiseth; Ritva Karinen; Asbjørg Christophersen; Jørg Mørland
Journal:  Int J Legal Med       Date:  2009-11-25       Impact factor: 2.686

9.  Change in access to prescribed medication following an episode of deliberate self-poisoning: a multilevel approach.

Authors:  Bergljot Gjelsvik; Fridtjof Heyerdahl; Daniel Lunn; Keith Hawton
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

10.  The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study.

Authors:  Ingeborg Rossow; Jørgen G Bramness
Journal:  BMC Public Health       Date:  2015-03-25       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.